Skip to content

Leica ASP300 S - 230-240V 000000014047643514Recalls & reported problems

Leica Biosystems Nussloch GmbH · The instrument has been designed so that it is safe to use by the operator as well as for process¬ing specimens – provided that it is operated according to the present Instructions for Use. The Leica ASP300 S is a modular tissue processor for the following laboratory applications: • Fixation • Dehydration • Paraffin infiltration of histological tissue specimens. · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 04049188055972), received between Dec 18, 2020 and Dec 11, 2025 — classified as 5 injuries.

The most frequently reported specific device problem is “Defective Component” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 1 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Defective Component2
  • Insufficient Device Problem Information2
  • Use of Device Problem2
  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available2
  • Tissue Breakdown2
  • Insufficient Information1
  • Unspecified Tissue Injury1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 11, 2025Use of Device Problem; Insufficient Device Problem Information; Use of Device Problem; Insufficient Device Problem Information

    ON 20 NOVEMBER 2025, THE CUSTOMER CONTACTED LEICA BIOSYSTEMS WITH THE FOLLOWING COMPLAINT: "THE TISSUE PROCESSOR COMPLETED THE PROCESS WITHOUT ERRORS BUT THE SAMPLES ARE TOO SOFT AND CANNOT BE CUT" ON 20 NOVEMBER 2025, THE LEICA HELP DESK SERVICE ENGINEER DOCUMENTED "THE CUSTOMER IS CURRENTLY REPROCESSING THE SPECIMENS AND WILL INFORM US IN THE COMING DAYS ABOUT THE OUTCOME." ON 25 NOVEMBER 2025,, THE LEICA HELP DESK SERVICE ENGINEER PROVIDED THE FOLLOWING ADDITIONAL INFORMATION "THE SAMPLES AFTER CUTTING ARE NOT VERY GOOD; THEY APPEAR ¿VITRIFIED.¿ IN ANY CASE, NOT ALL OF THEM HAVE BEEN REPROCESSED YET, AND NONE HAVE REACHED THE DIAGNOSTIC STAGE SO FAR." ON 09 DECEMBER 2025, THE LEICA HELP DESK SERVICE ENGINEER DOCUMENTED "UNFORTUNATELY, NOT ALL SAMPLES ARE DIAGNOSABLE. I SPOKE WITH THE CUSTOMER ON FRIDAY AFTERNOON (YESTERDAY WAS A NATIONAL HOLIDAY IN ((YESTERDAY WAS A NATIONAL HOLIDAY IN ITALY), AND THEY MENTIONED THAT THE HEAD PHYSICIAN WAS ASSESSING HOW TO MANAGE THE SITUATION AND TRYING TO SAVE AS MANY SAMPLES AS POSSIBLE. HOWEVER, THEY CONFIRMED THAT NOT ALL OF THEM WOULD BE DIAGNOSABLE. I ASKED FOR AN APPROXIMATE ESTIMATE OF THE NUMBER OF LOST SAMPLES COMPARED TO THE TOTAL, B

    Patient problems: Insufficient Information; Unspecified Tissue Injury

    MAUDE report 23786091 ↗
  • InjurySep 22, 2023Insufficient Device Problem Information; Insufficient Device Problem Information

    ON 16 AUGUST 2023 LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT THE CUSTOMER EXPERIENCED SUBOPTIMAL TISSUE PROCESSING ON THEIR LEICA ASP300S. ON 24 AUGUST 2023 THE CUSTOMER INFORMED LEICA BIOSYSTEMS, THAT AS A RESULT, 4 BIOPSY SAMPLES COULD NOT BE DIAGNOSED.

    Patient problems: Tissue Breakdown

    MAUDE report 17797785 ↗
  • InjuryFeb 12, 2021Defective Component; Defective Component

    ON 14 JANUARY 2021 LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT THE CUSTOMER EXPERIENCED DAMAGED TISSUE SAMPLES DURING PROCESSING ON THEIR (B)(4). AS A RESULT 3 TISSUE SAMPLES HAVE NOT BEEN DIAGNOSED, AND ON (B)(6) 2021 THE CUSTOMER INFORMED LEICA BIOSYSTEMS, THAT 3 PATIENTS HAVE TO BE REBIOPSIED.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

    MAUDE report 11320147 ↗
  • InjuryFeb 12, 2021Defective Component; Defective Component

    ON (B)(6) LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT THE CUSTOMER EXPERIENCED DAMAGED TISSUE SAMPLES DURING PROCESSING ON THEIR ASP6025. AS A RESULT 3 TISSUE SAMPLES HAVE NOT BEEN DIAGNOSED, AND ON (B)(6) 2021 THE CUSTOMER INFORMED LEICA BIOSYSTEMS, THAT 3 PATIENTS HAVE TO BE REBIOPSIED.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

    MAUDE report 11320142 ↗
  • InjuryDec 18, 2020Use of Device Problem; Adverse Event Without Identified Device or Use Problem; Use of Device Problem

    ON (B)(6) 2020, LEICA BIOSYSTEMS RECEIVED A COMPLAINT THAT THE CUSTOMER EXPERIENCED DAMAGED TISSUE SAMPLES DURING PROCESSING ON THEIR ASP300S. AS A RESULT TWO TISSUE SAMPLES HAVE NOT BEEN DIAGNOSED. THE CUSTOMER INFORMED LEICA BIOSYSTEMS, THAT TWO MEN WERE AFFECTED ABOUT THIS ADVERSE EVENT. THE AGE OF THE TWO DIFFERENT PATIENTS IS OVER 70 YEARS.

    Patient problems: Tissue Breakdown

    MAUDE report 11035169 ↗

Other PROCESSOR, TISSUE, AUTOMATED devices

All PROCESSOR, TISSUE, AUTOMATED devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page